Presenting Companies – 2025
2025 Presenting Companies!
Absurd Snacks is a consumer packaged goods company that creates inclusive, functional, and crunchy snacks. Their flagship product line, Chickpea and Granola Crunch Mix, pack 7g protein, 5-6g fiber, and are exclusively sweetened with pure maple syrup. Absurd Snacks is proud to be free from the top 9 food allergens and plant based. Absurd Snacks is available regionally in Whole Foods Market, nationally in the TJX Companies (HomeGoods, Marshalls, and TJMaxx), and available on Amazon Prime.
Anantyx Mission: Democratize cloud access by providing an intuitive platform that transforms complex cloud operations into seamless, cost-effective cloud environments for individuals, small to midsize businesses, the DOD and public sector agencies.
Problem: The rapid migration to the cloud has brought significant challenges. The complexities inherent in provisioning cloud environments can be overwhelming. Additionally, a lack of real-time visibility into cloud costs and resource utilization results in an average of 35% waste of cloud spend.
These issues have far-reaching consequences for organizations:
- Skyrocketing Costs
- Talent Retention
- Productivity and Innovation Stunted
- Mission Failure Risk
Solution: Anantyx Cloud Command (ACC) is a patented unified self-service platform that simplifies Cloud Management and Remote Desktop Access. Provision environments fast, control costs in real time, and keep your team productive from anywhere within a secure Enhanced Virtual Desktop Infrastructure (eVDI). Gain visibility and control over cloud costs at the project and team level. Make informed decisions with real-time pricing information before provisioning resources. By leveraging ACC an organization can unlock the full potential of the cloud and achieve unprecedented levels of efficiency and cost savings.
Experience the Benefits:
|
|
|
|
|
|
Avant Genomics is a UVA spin-out advancing AvantDuet, a next-generation laboratory platform that automates the most complex step in liquid biopsy: sample preparation. Current workflows require dozens of manual steps, hours of technician time, cost over $100/sample, and can lose up to 95% of tumor DNA – compromising patient results. AvantDuet reduces this to two manual steps, cutting costs by 84%, time by 50%, and improving DNA recovery.
The system combines a benchtop instrument ($75k) with disposable cartridges (12x, $150/cartridge) and service contracts ($5k/year), creating recurring revenue with rapid customer payback. Feedback from Haystack Oncology (Quest Diagnostics), Johns Hopkins, Frederick National Labs, and AstraZeneca validates strong demand ahead of our Early Access Program in 2026.
Supported by nearly $500k in grants and an exclusive IP agreement with UVA, Avant has demonstrated 100% concordance with results from UVA Cancer Center and sensitivity down to 0.2 ng/μL, a clinically relevant range for cancer testing. Led by co-founders Drs. Rachelle Turiello (CEO) and Renna Nouwairi (COO), Avant is raising a $3M seed round to scale manufacturing and bring AvantDuet to the $8.7B liquid biopsy laboratory products market.
Blue Vigil is making nighttime workers safer and more productive by leveraging state of the art technology to completely transform how work sites are illuminated. Our patented portable light uses tethered drone technology to provide twice the illumination of conventional towed light towers without the dangerous glare and shadows. This category-defining product targets construction, public safety, disaster response, mining and other segments of the growing $5B/year market for portable light towers.
Bowerbags is a modular equipment company focused on enhancing the speed, safety, and efficiency of the aeromedical mission. The company developed the patented Modular Quick Release System (MQRS)—the only MOLLE-to-Aircraft, Aircraft-to-MOLLE attachment system designed to improve aeromedical mobility for the U.S. Air Force. Created in collaboration with the Air Force Research Laboratory (AFRL), MQRS features a self-locking, rapid “no-tool” connection system that enables quick reconfiguration of aircraft interiors and storage solutions. It allows multiple medical devices to be attached to an optimized LSAS system or fully integrated into a new LSAS design. This tool-free setup enables smaller 2–3 person AE teams to rapidly load, stabilize, and care for patients in constrained or contested environments.
Bravado Engineering is the home of the patented HERO (Health Real-time Observer) system, which fills the real-time data gap encountered by law enforcement officers during an apprehension. HERO measures and assesses biometric data during the apprehension process, analyzes that data using a proprietary algorithm, and then displays all data in the HERO software application. If an apprehended individual’s health status deteriorates, HERO alerts the officers on the scene, via an audio and visual alert, or remotely using the HERO software application. Our system, comprising both hardware and software, provides police officers, sheriff’s deputies, and other law enforcement officials with the data and insight needed to make apprehensions more transparent, more efficient, and safer.
We are building an urban mining company . Our embedded circularity platform uncovers materials, critical minerals, and reusability within deployed assets. Conservative estimates indicate that the value of metals embedded in the U.S. economy is $2.8 trillion, concentrated in electronic waste, which will inevitably face end-of-life. In 2024, only 22% of U.S. e-waste was recycled – this is a missed opportunity to recover value, retain critical minerals, and reduce environmental impact.
CargoClear Technologies, Inc. is a supply chain risk assessment company that uses legacy and emerging technologies to detect and report the risk of purchasing products from a supply chain before the purchase is made. This allows businesses to make better decisions in purchasing products to avoid issues that can cost them millions of dollars in fees, fines, penalties and delays. We incorporate blockchain ledger technology, machine learning, personal knowledge, and regional customs to ensure the information obtained is accurate and timely.
Carrylug is a peer-to-peer international shipping platform that makes sending and receiving goods across borders easier, faster, and more affordable. Instead of relying only on expensive courier services, Carrylug connects senders with travelers who have extra luggage space, turning every journey into a smarter logistics solution. Senders save money and gain access to items that may not be available locally, while travelers earn extra income simply by carrying goods they already have room for.
More than just shipping, Carrylug also allows travelers to purchase products abroad on behalf of senders, opening up new possibilities for families, students, and small businesses. Whether it’s a loved one sending essentials back home or a small shop looking for unique products, Carrylug creates a convenient and personal way to connect communities worldwide.
The platform is designed with security and transparency in mind. Features include flexible payment options, live shipment tracking, ratings and reviews, and a tiered trust-verification system to ensure safety on both sides. For businesses, Carrylug also provides opportunities to promote services and reach a wider audience without heavy marketing costs. With Carrylug, international shipping becomes more reliable, community-driven, and affordable—helping people stay connected across borders every step of the way.
Clareo Biosciences has developed the world’s first comprehensive adaptive immune receptor profiling platform to address a critical blind spot in precision medicine. Current technologies miss the immunogenetic variation that drives differential patient responses and adverse events across therapeutic areas—from oncology to autoimmunity to infectious disease. Our proprietary technologies provide complete characterization of all 11 immune receptor loci, linking both antigen binding and effector functions in single transcripts to reveal unprecedented insight into individual immune system diversity. This foundational intelligence enables safer and more effective drug development, vaccine design, clinical diagnostics, and precision treatment delivery. Our newly operational laboratory (launched February 2024) serves pharmaceutical companies, biotech firms, clinical researchers, and academic institutions seeking to understand the immunological factors driving variable treatment outcomes.
Critical Shift eliminates uncertainty for tactical teams and industrial systems by providing secure wireless mesh systems with Edge AI. Our HaulerOS system helps transmit critical information from the edge to decision-makers without relying on public infrastructure. Wireless mesh technology is challenging to deploy, challenging to secure, and most of today’s equipment comes from untrusted supply chains. Critical Shift offers a trusted supply chain, integrated security, fast and reliable mesh, easy configuration, and Edge AI capabilities. Our existing clients are government and military focused and we’re currently trying to expand into critical infrastructure based on some inbound demand for these systems.
Diogenes FG is a specialized governance advisory and technology firm dedicated to strengthening fiduciary oversight in today’s most complex risk areas. Building on decades of experience in fiduciary governance for boards and investment stewards, Diogenes FG provides innovative frameworks, tools, and resources that help organizations meet—and document—their duty of care.
Our flagship initiative, CyberGov™, is the first patent-pending Agentic AI platform designed to support corporate boards in meeting their cybersecurity fiduciary obligations. CyberGov™ continuously monitors board decisions and actions against industry standards, including the Govern (GV) function of the NIST Cybersecurity Framework 2.0 and ISO 19011 auditing guidelines. By producing clear, audit-ready reports, it gives directors confidence that they are fulfilling their fiduciary responsibilities, while reducing the risk of personal liability in the event of a cyber breach.
With a history of shaping global fiduciary standards now used across North America, the UK, EU, Australia, and New Zealand, Diogenes FG combines proven governance expertise with cutting-edge AI innovation. We have advised manufacturing associations, companies, and a sovereign fund to refine best practices, provide board-level education, and ensure that stewardship, compliance, and accountability remain at the heart of enterprise leadership.
ElectroTempo provides AI-powered geospatial intelligence to forecast and optimize energy-infrastructure deployment across multiple high-growth sectors. Our mission is to solve the challenge of AI power-demand stress on infrastructure: data centers, electrified logistics, and other emerging loads are straining utilities and property owners with unprecedented uncertainty about where, when, and how much power will be needed. ElectroTempo’s platform creates a living “digital twin” of future demand by unifying satellite imagery, facility activity, grid assets, and land-use layers into a single scalable pipeline.
Our first wedge is electric vehicle charging, where fragmented planning tools have slowed deployment and wasted capital. By automatically detecting and sizing truck depots, warehouses, and industrial sites, our AI pipeline simulates adoption, load profiles, and utilization patterns to recommend the lowest-cost infrastructure phasing. Customers include utilities, commercial real-estate operators, ports, and fleets who use our software to compress timelines and unlock ROI.
Beyond EVs, ElectroTempo is expanding into data centers and nuclear microreactors—where we already have partnerships in the nuclear space to co-optimize siting and load balancing. With proprietary datasets, fully automated workflows, and defensible AI models, we are building the category-defining platform for forecasting and optimizing energy infrastructure in an era of explosive demand growth.
Ellexco is pioneering the next generation of sustainable, high-efficiency lithium extraction through an electro-driven direct lithium extraction (DLE) technology. As global demand for lithium surges—driven by EVs, grid storage, and digital electrification—Ellexco offers a transformative solution to one of the industry’s most urgent bottlenecks: scalable, clean, and cost-effective lithium supply. Ellexco replaces the outdated process and expands unconventional lithium resources with a chemical-free, electricity-powered solution that reduces salar extraction time from years to hours, enables lithium recovery from untapped unconventional sources, works with various lithium concentration brine sources, cuts production costs by up to 50%, minimizes land and water usage, achieves net-zero carbon emission and environment pollution. The technology has been recognized as the top 3 emerging technologies by the US Department of Energy. Ellexco was co-founded by Dr. Lingchen Kong and Dr. Xitong Liu in 2023.
EqualityMD’s national, insurance-free, B2B SaaS telehealth + FREE Rx and data analytics platform delivers cost-saving, culturally competent care to employers of all sizes and new AI-powered insights to health companies. Instead of passing rising health costs onto employees, employers can incorporate EqualityMD’s national telehealth platform into their HR/employee benefit plans. Our digital platform compliments employers’ existing insurance plans, which can be reserved for all non-telehealth related needs.
EqualityMD’s comprehensive telehealth platform diverts 56% of expensive employer-sponsored insurance claims by resolving 70% of employee health needs, saving employers 20% and employees 25% in annual health costs. Our enviable independence from America’s broken insurance-based health system makes us immune from partisan health policies and payors’ volatile health plans.
EqualityMD’s inclusive telehealth solution is a powerful HR tool that can help attract and retain talent, a dynamic marketing resource that can help for-profit and non-profit companies authentically engage new demographics, and a cost-saving, first line of defense against skyrocketing healthcare expenses. Our new AI-powered insights can help health companies authentically engage new patient populations, develop more accurate predictive analytics, and lower health costs for all Americans.
Mark Baldino had a thought that there are smoke detectors everywhere too bad they just warn you of a fire what if they could put one out. With modern technology assembled correctly it could be done, concentrated over the kitchen stovetop where over 50% of all residential fires start, FireBot can stop half of residential fires. No small feat in the firefighting world. No one in the firefighting world can say they can instantly stop over half of fires that start without damage. We can, FireBot Inc was formally founded in 2017, is headquartered in Springfield VA. Since releasing the prototype in 2019.
FireBot was awarded a patent for the technology and has subsequently filed for follow-on patents, for Shelf Guard and the world’s first electronic fire extinguisher. With the initial concept proven, FireBot has assembled a world class team of scientists, engineers, sales, and marketing people to perfect the concept into reality where in the first year of sales we have sold over 13,000 units.
Floreo is an evidence-based virtual reality platform designed to help neurodivergent individuals build real-world skills in a safe, engaging environment. With over 200 immersive lessons, Floreo supports areas like communication, emotional regulation, and daily living skills. Coaches (educators, therapists, or family members) guide sessions using a browser-based platform, while Learners use a compatible VR headset. Floreo is used in homes, schools, and clinics across the U.S. and internationally.
Fundaira is an AI-powered marketplace that connects vetted NGOs with aligned donors. NGOs gain donor diversification and discover new funding opportunities, while donors gain visibility into trusted, locally rooted organizations they can’t easily find elsewhere.
Fundaira operates on a SaaS subscription model in which donor participation helps subsidize NGO access, ensuring broad adoption while capturing value from both sides. Our revenue model includes donor and NGO subscriptions, and a percentage of successful funding flows.
We are piloting with NGOs across multiple regions and supported by advisors from both the donor and NGO sides, giving us early validation of product–market fit. Fundaira is women-led and mission-driven, co-founded by a team that brings both AI/fintech expertise and over 20 years of NGO advocacy and fundraising experience. Our focus is on strengthening civil society and ensuring that donor capital reaches organizations closest to the communities they serve. By structuring NGO and donor data and applying explainable AI, we create defensible network effects: the more participants we onboard, the stronger and more valuable the matches become. We are raising $1M to scale NGO and donor onboarding, accelerate product development, and expand into a full two-sided marketplace, positioning Fundaira to address a multi-billion-dollar gap in global nonprofit funding.
Glacier21 was founded by former FBI/DOJ leaders and expert developers to combat illicit cryptocurrency activities. Our government-grade commercial risk intelligence solution uniquely integrates on-chain and off-chain data to untangle complex connections across blockchain wallets, businesses, and individuals. Unlike traditional blockchain solutions, Glacier21 prioritizes off-chain data by scraping, aggregating, and validating sources such as web3 social platforms, data leaks, code repositories, sanctions alerts, and the deep/dark web. Using AI-driven analysis and labeling, we have curated a database of 141M+ labeled wallets, 301M+ off-chain tags, and 16M+ on-chain labels. Continuously updated through automation, our datasets provide current and dynamic insights. Glacier21 empowers compliance departments, financial institutions, corporations, exchanges, and government agencies to efficiently detect wallets linked to illicit activities like terrorism financing, fraud, money laundering, ransomware, and sanctions evasion. Our solution enables proactive risk mitigation and regulatory compliance, ensuring stakeholders access the most comprehensive and actionable intelligence available in the cryptocurrency ecosystem.
GoodFences is revolutionizing how Homeowners Associations (HOAs) operate with our patent-pending, AI-powered SaaS platform. HOAs have traditionally relied on outdated, manual processes that are slow, inconsistent, and costly. These inefficiencies result in delays that frustrate homeowners, approvals that can take four to six weeks, and administrative costs that drive HOA dues up by an average of 24% annually.
GoodFences automates these processes end-to-end. Our AI approval engine makes near-instant, bias-free decisions, reducing timelines from weeks to seconds and cutting administrative costs by up to 50%. This creates a faster, fairer, and more transparent experience for homeowners while giving HOA boards and staff the ability to focus on what matters most — building strong, connected communities.
In addition to automation, our platform offers intuitive dashboards and real-time insights, enabling HOA managers to spot issues early, maintain compliance, and operate more efficiently. By partnering with leading HOA law firms, we ensure compliance and create a trusted path to adoption. Our vision is to make GoodFences the global standard for digital community governance, transforming how neighborhoods are managed worldwide.
GovDoc.ai provides a fully integrated automation layer for GovCon businesses. We build custom integrations that connect the disconnected systems contractors rely on — from opportunity search and pipeline management to proposal generation and compliance workflows. Instead of relying on manual processes, GovDoc.ai automates repetitive tasks, extracts key data from solicitations, and streamlines decision-making. Our approach is not a one-size-fits-all SaaS, but tailored automation designed around how each government contractor actually works. The result: faster bid/no-bid decisions, leaner proposal cycles, and higher win rates at a fraction of the traditional cost.
InvisibleID is a deep-tech startup pioneering advanced multi-bit watermarking solutions for AI-generated text and code. As artificial intelligence becomes integral to industries ranging from finance and law to software development, questions of authorship, accountability, and trust have become urgent. Current watermarking methods are often fragile, limited to single-bit detection, or easily removed through paraphrasing and code refactoring. InvisibleID is addressing this gap by developing robust, distortion-free multi-bit watermarking algorithms that can embed rich metadata—such as user identity, model provenance, and timestamps—directly into generated outputs without altering meaning or functionality.
Our technology ensures verifiable traceability across AI-driven workflows, enabling enterprises to protect intellectual property, comply with emerging regulations, and maintain secure software supply chains. Unlike traditional detection-only tools, InvisibleID’s solution provides a scalable framework for embedding and verifying information, resistant to adversarial attacks and compatible with any large language model.
InvisibleID’s mission is to become the trusted standard for watermarking in AI, offering SaaS-based services to startups, enterprises, and organizations integrating generative models into critical operations. By delivering accountability and transparency, we empower businesses to adopt AI confidently while reducing legal, security, and compliance risks.
Jeeva Clinical Trials is a next-generation unified platform designed to transform the way clinical research is conducted worldwide. Founded by Dr. Harsha K. Rajasimha, a precision medicine data scientist and rare disease advocate, the company was born out of both professional expertise and deeply personal experiences. After losing a child to a rare congenital disorder, Dr. Rajasimha committed his career to accelerating patient-centric research and ensuring that no family should suffer due to delayed or inaccessible clinical trials.
Professionally, Dr. Rajasimha spent over 20 years leading teams in genomics, bioinformatics, and regulatory science at the U.S. National Institutes of Health, U.S. Food and Drug Administration, and in the biotech industry. These experiences exposed him to the inefficiencies and fragmentation of existing clinical trial infrastructure, inspiring the creation of Jeeva as a unified or modular solution.
Jeeva’s software suite integrates Clinical Trial Management System (CTMS), Electronic Data Capture (EDC), electronic Clinical Outcomes Assessment (eCOA), eConsent, tele-visits, and patient engagement tools into one secure, cloud-based platform. By leveraging automation, AI, and mobile-first design, Jeeva helps sponsors, contract research organizations (CROs), and academic centers reduce trial timelines, improve compliance, and expand access for diverse patient populations globally. Guided by its founder’s vision, Jeeva is committed to making clinical trials faster, cost-effective, and inclusive—ultimately accelerating cures for patients everywhere.
Jericho Sciences is developing novel antiviral therapeutics and personalized diagnostic assays which specifically address the limitations of current standard of care therapies in the clinical management of chronic virus infections.
Our current focus is chronic Hepatitis B Virus (HBV) infection, responsible for 30% of all cases of liver cirrhosis, 45% of liver cancers and nearly 1 million deaths each year. Chronic HBV affects 300 million people globally. There are no approved drugs to cure chronic HBV. Our lead small molecule, JS103, represents a new drug class and mechanism of action with a good preclinical safety profile useful for curing chronic HBV infection by inactivating and reducing the viral cccDNA reservoir – the primary obstacle to eradicating this persistent infection.
Kinumi is a tech-enabled concierge platform transforming how older adults and their caregivers navigate health, wellness, and daily living. Launched in 2022 after emerging from stealth, Kinumi delivers care coordination and insurance-billing capabilities while building next-generation tools in AI-driven predictive insights, a curated services marketplace, and social engagement.
We address a critical and growing need: by 2030, one in five Americans will be over 65. Kinumi helps families simplify fragmented care by combining benefits navigation, proactive health support, and trusted service connections into one seamless experience. For employers, insurers, and partners, Kinumi creates measurable cost savings, improved engagement, and better outcomes.
Building on early recognition through Techstars, Comcast NBCUniversal’s LIFT Labs, and Rock Health, we are now expanding into reimbursable benefits as a Medicare provider. As we develop scalable AI and machine learning capabilities alongside a robust marketplace, Kinumi is positioned to redefine how aging and caregiving are supported. We are seeking investment to accelerate this expansion and advance our mission of helping millions of older adults age well and families care better.
LASARRUS Clinic and Research Center
LASARRUS is pioneering remote COPD care with WearME‑Pro, the first wearable that matches the precision of gold‑standard spirometry using bilateral acoustic sensors and AI. WearME‑Pro delivers multimodal respiratory insights as a $76 per‑patient per‑month SaaS; the hardware is loaned at no capital expense and reimbursed through eight remote patient monitoring codes. By detecting flares up to 48 hours earlier and providing actionable insights, the platform reduces nurse triage time by ~50 %, decreases ER visits by at least 20 % and lowers readmissions by 15 %.
We operate a B2B model: hospitals, RPM aggregators and COPD specialty clinics prescribe WearME‑Pro, and reimbursement comes from Medicare, Medicaid and commercial insurers. Pilot agreements with Johns Hopkins, TidalHealth and Tower Health give us access to more than 50 000 COPD patients.
Our team has secured four issued patents, has five pending and has won three SBIR grants and the Intel Wearables contest. The serviceable addressable market for COPD telehealth was $1.36 B in 2022, is growing at a 14.8 % CAGR and is projected to exceed $1.8 B by 2025. WearME‑Pro’s precision, predictive analytics and reimbursement‑friendly business model uniquely position LASARRUS to transform COPD care.
Linebird, Inc. is a pioneering technology company based in Virginia, specializing in unmanned aerial systems (UAS) designed for live-line maintenance on high-voltage power infrastructure. Founded out of Virginia Commonwealth University undergraduate research, Linebird has developed the Osprey Nonconductive Payload System (NPS), an innovative solution that allows drones to perform hands-on work on energized power lines without the need for de-energizing them. This groundbreaking technology enhances safety for utility workers, significantly reduces operational costs by up to 90%, and improves overall efficiency in utility operations.
The Osprey NPS features a modular design that supports various applications, including inspections, repairs, and equipment transport, making it a versatile tool for utility companies looking to modernize their operations. Linebird is committed to fostering partnerships within the utility sector, collaborating with major companies like Dominion & Duke Energy and helping customers secure funding from the American Public Power Association’s DEED program to evaluate and implement its technology.
With a focus on safety, efficiency, and sustainability, Linebird is poised to transform the landscape of utility maintenance, paving the way for a more resilient energy infrastructure and setting new standards for how drone technology can be utilized in the energy sector.
Linshom Medical is the first to deliver an operating room (OR) quality respiratory profile to the patient bedside or home for continuous, predictive respiratory monitoring (CPRM). This wearable, AI enabled, FDA cleared sensor provides advance notice of respiratory decline avoiding costly rapid response activations, rescue events (codes), ICU transfers and deaths. Current technology (OR & ICU) is not transferable to the patient bedside because it is too large, complex and expensive.
Liquet Medical is a med-tech company developing the Versus™ Catheter, the first dual-tip, real-time hemodynamics-guided infusion system designed for pulmonary embolism (PE). Unlike mechanical thrombectomy or legacy catheter systems, Versus delivers thrombolytics into both lungs simultaneously while continuously monitoring pulmonary artery pressures. This enables physicians to personalize therapy, reduce drug exposure, and observe clot resolution in real time.
Liquet has achieved FDA 510(k) clearance on their first product and now has a second product ready for submission to the FDA. Liquet has also launched its first-in-human study at UVA and is preparing a pivotal IDE trial to support expanded indication and commercialization. By combining clinical innovation with capital efficiency, Liquet is positioned to transform PE care and create meaningful value for patients, physicians, hospitals, and strategic partners.
milkmade is where science meets the art of lactation.
Our first MVP is a patent-pending smart nipple shield, a device worn during breastfeeding.
The milkmade nipple shield measures breast milk output directly from breast into baby’s mouth, while also identifying latch quality.
The flow and latch sensors report into the milkmade app and provides user insights with AI/ML, including Telehealth support.
The AAP and NIH cite the #1 reason for breastfeeding cessation is perceived low milk supply and actual low milk supply. With milkmade, we can finally answer the question, “Am I making enough breastmilk for my baby?”
NearStar Fusion Inc. is an energy startup based in Chantilly, VA, developing a nuclear fusion machine capable of generating high-energy neutrons to create on-demand medical isotopes (e.g. Ac225, Lu177) for cancer therapies and diagnostics.
Led by Dr. Douglas Witherspoon, the technical team has worked together for over 15 years in fusion energy R&D. Our work includes developing and producing high-performance plasma guns for fusion experiments at Los Alamos National Laboratory.
NearStar Fusion’s method to create medical isotopes will help drive down costs and increase availability. Coincidentally, fusion energy is regulated under the same code (10 CFR Part 30) as nuclear medicine allowing the co-location of isotope production with treatment centers.
NearStar Fusion’s longer term plans (7-10 years) are to augment the fusion machine into a power plant for affordable, clean, and safe baseload electricity (50-100MW) both on and off-grid.
NearStar’s proprietary approach combines the ability to simultaneously compress and magnetize hydrogen at hypervelocity (e.g. 11,000 mph) to create fusion reactions generating high-energy neutrons. The design is rare-earth material free and will use commercial-off-the-shelf (COTS) components. The entire NearStar fusion machine can easily fit inside a standard warehouse and is easier to operate than a cyclotron or particle accelerator.
Neuros Bio is a neurobiotechnology company pioneering regenerative therapeutics for central nervous system (CNS) disorders. Our platform leverages a human-derived, acellular mixed biologic, licensed under a Material Transfer Agreement from Japanese partners, that has already demonstrated safety and efficacy in Phase I/II trials for liver regeneration. Neuros Bio repurposes this biologic to target neuroplasticity, with early data showing glial and neuronal proliferation, and external studies reporting cognitive improvements in treated animal models.
We are developing a robust IP portfolio across high-burden CNS indications including Alzheimer’s, PTSD and Depression. Neuros Bio is part of the Johns Hopkins Technology Ventures program, with lab space on campus and JHTV holding an equity stake. Our scientific advisory board includes global leaders in Alzheimer’s and neuroplasticity from Johns Hopkins and King’s College London.
With early funding from TEDCO and active SBIR grant submissions to NIA and NIMH, we are positioned for rapid preclinical advancement. Neuros Bio is currently raising $1.3M in seed capital via convertible notes to accelerate IND-enabling studies and expand our neurotherapeutic pipeline. Our mission is to unlock the brain’s regenerative potential and redefine treatment paradigms for neurodegenerative and neuropsychiatric disease.
Nightingale Caring Solutions provides a web-based software platform that streamlines nursing workforce operations. Its first product focuses on optimizing the development of nurse-patient assignments. Nurse-patient assignments are widespread, as they are developed at least twice per day on each unit in more than 6,000 hospitals in the United States and they are significant because how they are developed impacts costs and outcomes for nurses and patients. Nightingale modernizes this process, which is currently often completed on paper and with no data, by empowering nurses to design customized algorithms that generate evidence-based nurse-patient assignments in seconds.
Novva Biosolutions is a Baltimore-based femtech startup pioneering a new period in menstrual health with biomedical innovation and user-centered design. Founded by Dr. Danielle Nicklas, the company is developing the NovvaCup, a patent-pending, ergonomically engineered menstrual cup made of 100% medical-grade silicone. Unlike rigid, static cups that dominate the market, NovvaCup features a collapsible, multi-phase design that simplifies insertion, ensures comfortable wear, and enables clean removal. This approach directly addresses the top reasons why fewer than one in four U.S. menstruators adopt reusable cups, despite their sustainability and cost benefits. By combining innovative design with community-driven health education programs such as our Flower Power curriculum, NovvaCup is positioned to capture market share in the $1.9B menstrual cup industry and expand into the rapidly growing women’s health sector through future diagnostic applications.
With a developed prototype (TRL 4, MRL 4), NovvaCup has surveyed over 400 women and secured 53 pre-registrations for beta testing, validating strong interest and demand. The company has raised $88,350 in non-dilutive funding through Johns Hopkins, Loyola University, Maryland Innovation Center, and other partners, and is now preparing a $500,000 pre-seed round to support FDA registration, manufacturing, and product launch.
Nowy – Now We Go is built for spontaneous trips discovered through social media. While 80% find travel inspiration on social platforms, only 32% ever book due to: overloaded information, overwhelming price anxiety, and overlooked AI recommendations.
Nowy solves this with proprietary agentic AI that instantly transforms TikTok, Instagram, and YouTube content into visual, bookable itineraries. Our breakthrough auto-rebooking technology monitors prices daily, automatically canceling and rebooking lower rates while charging only a percentage of savings.
With 11,000+ users, 4.9-star rating, and proven booking revenue through 100% organic growth, we’ve validated demand for optimized travel experiences by removing friction between ideas and action. Backed by JP Morgan, AWS, and Google for Startups, Nowy restores spontaneity by revolutionizing travel friction into travel magic.
OpenVetting provides a structured reasoning interface for managing disagreement in high-stakes settings. It enables experts and institutions to host arguments in a claim-ledger format and to challenge each other at the idea level. Powered by HI/AI teaming, the platform combines human critique with AI framing in a forum where visible reasoning, open peer-review, and thoughtful dialogue set a higher standard for public confidence.
QWERX is a cybersecurity company that eliminates external network breaches caused by static credentials with a revolutionary approach to securing devices—stopping sophisticated hackers in their tracks.
Most enterprises are woefully exposed to growing threats because digital credentials used for machine identity authentication are easily harvested and misused for illicit network access. The QWERX software continuously authenticates and protects devices with dynamic, ephemeral keys that are used only once every few seconds, leaving nothing for a hacker to steal. QWERX simplifies machine identity management, reducing both cybersecurity risk and the resources needed to protect networks.
ReMinded is a medical device startup commercializing the first, clinical-grade saliva test for cortisol to bring objective data into psychiatry. Our 5-10minute test enables clinicians to reduce relapse rates and improve outcomes in PTSD and addiction care. In under a year of U.S operations, we raised $1M+, launched our first clinical trial with Hoag Memorial Hospital and secured IDE approval from the IRB on the first attempt. With FDA clearance and commercialization planned for 2026, we’re positioned to lead salivary diagnostics in behavioral healthcare.
Rohic is a multi‑agent orchestration platform that delivers autonomous go‑to‑market (GTM) agents across the full funnel – from outbound prospecting to renewal – with human‑grade control. Our platform provides a coordinated AI “virtual GTM team” that plans, executes, and hands off work end‑to‑end. Seven specialized agents – Outbound Prospector, Lead Scoring & Routing, Meeting Scheduler, Proposal & Deal Desk, Conversation Coach, Revenue Intelligence, and Customer Success & Renewal – are orchestrated by the Conductor Engine on a governed Unified Data Hub. Every action is visible and controllable in the Command Center (approvals, audit trails, policy enforcement), and all outputs stay on‑brand via our Sales Story Engine™. Teams go live in days using the No‑Code Orchestration Studio, while adaptive multi‑LLM routing with caching keep unit economics predictable.
In early pilots, teams cut content creation time by ~40%, moved proposals from days to same‑day, and reduced inbound response to under 15 minutes. The result: higher pipeline quality, lower cost per rep, and better conversion. We’re focused first on cybersecurity and IT services, then expanding into adjacent B2B SaaS via vertical Agent Packs and a land‑and‑expand motion.
SalivIQ Diagnostics is transforming disease detection with saliva-based testing, offering a noninvasive and reliable alternative to throat swabs. Our flagship test, SalivIQ™ Strep A, is the first saliva diagnostic for strep throat. Results from a 102-participant clinical study show that SalivIQ™ Strep A is 100% accurate, meaning repeat follow-up testing is not necessary and a definitive diagnosis is achieved in as little as 22 minutes. SalivIQ™ enables for saliva self-collection at check-in, which reduces provider burden, streamlines workflows, and shortens visit times, resulting in up to $72K increased revenue per provider annually due to faster exam room turnover and the ability to see more patients in a day. Our growing molecular diagnostic platform will deliver fast, accurate results for strep, COVID, flu, and mono from a single saliva sample.
Sonogen Medical is developing an agentic fracture assessment (AFA) capability, based on a combination of proprietary and patent-pending technology. Our highly innovative AFA technology uses artificial intelligence (AI) and digital signal processing to diagnose fresh fractures, and also monitor the fracture healing process. We initially intend to license our healing monitoring technology for complementary use in diagnostic ultrasound equipment, as well as bone growth stimulation devices. We also have plans to develop a stand-alone fracture diagnosis device. The total market for our technology, including monitoring and diagnostics, is around $4B annually. We have raised just under $1.8M to date, and are just about to open a $2.0M bridge round on a $10M pre-money valuation.
Spectrohm is taking the friction out of inspecting bags and packages using patented radio wave technology. Today’s human-centric tools can only see inside 3% of the 400 billion bags and packages that move each year, leading to $100Bn in losses. Spectrohm’s CheckStream and CargoStream products help governments, venues, and eCommerce businesses detect threats, enforce tariffs, and prevent fraud—faster, more accurately, and at a lower cost than traditional methods.
SRT Labs is a VA-based woman-owned small business that has built a patented, hardware-agnostic interoperability framework (M1 Platform) that connects legacy and modern infrastructure systems into a unified data ecosystem. SRT’s technical approach, validated by prior commercial and DOD success, is to create the data plumbing for siloed infrastructure systems to bring it all together into a Unified Data Layer and provide a single pane of glass to our customers. Their work enables real-time monitoring, automation, and AI/ML readiness across smart buildings, utilities, and defense environments. SRT Labs focuses on the maintenance, repair, and overhaul systems that are required to ensure ships, vehicles, and aircraft are quickly returned to the field. With deployments across commercial and GovCloud IL2/IL4/IL5 environments, NIST 800-171 compliance, and a sole-source contracting vehicle in place, they have demonstrated past performance in:
- Navy and Marine Corps deployments for facility, machinery, and infrastructure health monitoring,
- Marine Corps logistics and smart warehouse automation with 5G applications,
- Integration with Navy Unified Data Layer (UDL) efforts,
- Subcontractor support to the Naval Research Lab under Peraton’s on-orbit satellite servicing work,
Storly.ai is an AI-powered conversational storytelling and B2B SaaS marketing platform that helps nonprofits turn their community stories into powerful fundraising content automatically. It collects, writes, and packages real stories from the people they serve to boost donations and reduce staff workloads.
Torev is developing the world’s highest performance rare earth free electric motors for defense and automotive vehicles. The company’s patented technology enables superior vehicle performance, extends vehicle range, and fully insulates supply chains from rare earth metals. The company is SBIR funded by the US Army, has received term sheets to license this technology from automotive Tier 1 suppliers, and won the 2024 Global Automotive & Mobility Innovation Competition in Detroit, MI.
Urban Reblokd Inc is a one of a kind operation. We are able to take #1-#7 mixed plastics and without sorting we are able to turn them into building materials, everything from cinder blocks to railroad ties to anything else that lumber has been used for. We are also tackling the agricultural film industry, a very dirty and underserved industry. We are able to take that film, clean it, and then pelletize it for reuse in the manufacturing process for other manufacturers. This funding is to establish a hub location in Virginia. Urban Reblokd will be placing locations all over the country and all over the world with our machinery and processes.
VroomBrick is a real estate technology company transforming the way people buy and sell homes. Instead of paying 3–6% realtor commissions, users pay a streamlined 1% technology fee. Built like TurboTax for real estate, our platform gives buyers and sellers step-by-step transaction workflows, real-time dashboards, and direct access to lenders and closing attorneys. With VroomBrick, anyone can take control of their home transaction, save thousands, and move forward with confidence through a process that is simple, transparent, and fully supported.
ZipIDapp is an I-9 automated SaaS solution that solves issues of identity and ID verification, compliance, speed, accuracy, ease of use, and privacy for employers and new hires, both of whom must complete portions of the I-9. Customer discovery has verified that ZipID’s ease of use to solve a current employer multi-faceted headache is a current market need. The uptick in ICE I-9 raids coupled with job applicant fraud heightens the need for employers to use the I-9 to their advantage to verify the identity of their new hires while assuring fool-proof compliance.